Drug registrationNational has managed to pull another rabbit out of the hat, some of the cancer drugs still need to be registered, allegedly. “We’re looking to deploy the cancer drugs that we campaigned on. But Chris Luxon puts the cart before the horse and now tries to blame procurement for not funding the 13 new cancer drugs. There are additional considerations to enable access to the cancer drugs such as from workforce and system capacity limitations. By sabotaging the procurement process led by PHARMAC Luxon has all but guaranteed a sub-optimal outcome.

Source: Stuff June 05, 2024 11:05 UTC